| Literature DB >> 26949468 |
Sanganagouda Patil1, Kunal Chandrakant Shah1, Shekhar Yeshwant Bhojraj1, Abhay Madhusudhan Nene1.
Abstract
STUDYEntities:
Keywords: Giant cell tumor; Intralesional curettage; Radiotherapy; Recurrence; Risk factor
Year: 2016 PMID: 26949468 PMCID: PMC4764524 DOI: 10.4184/asj.2016.10.1.129
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Epidemiological details of the patients
Fig. 1Case 6 with two recurrence. (A) Sagittal T1 and T2 magnetic resonance images (MRI) of MRI showing lesion in T10 vertebra. (B) Postoperative radiograph (anterior debridement and fixation done elsewhere). (C) Computed tomography (CT) myelogram image at 3 months showing recurrence and block at affected level. (D) Postoperative radiograph after first recurrence (posterior intralesional curettage with additional posterior fixation). (E) CT images showing recurrence with posterior implant loosening at 3 years. (F) Postoperative anteroposterior radiograph (revision posterior instrumentation and decompression). (G) Radiograph at the 10-year follow-up showing no recurrence and well places implants. (H) CT scan at 10 years showing no recurrence.
Fig. 2Case 5 with single recurrence. (A) Sagittal magnetic resonance image (MRI) showing pathological fracture at L2. (B) Axial MRI showing lesion. (C) Coronal MRI showing lesion. (D) Immediate postoperative radiograph (posterior decompression with Hartshill stabilization with anterior bone grafting). (E, F) Computed tomography images show recurrence after 8 years. (G) Radiograph at the 10-year follow-up after second recurrence surgery showing sclerosed bone and no recurrence.
Fig. 3Case 2 with single recurrence. (A) Computed tomography (CT) image showing recurrence with well placed previous implants. (B) Radiograph at 10 years showing no recurrence. (C) CT image at 10 years showing no recurrence.